Christin Neuber
Dresden, SN 01328, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Novel PSCA-Targeting Adapter Molecules for Late-Stage RevCAR-T Cell Therapy in Prostate Cancer.
Journal: International journal of molecular sciences
Published: June 03, 2026
Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.
Journal: ACS pharmacology & translational science
Published: November 14, 2025
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.
Journal: EJNMMI radiopharmacy and chemistry
Published: April 22, 2025
Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging Experiments.
Journal: International journal of molecular sciences
Published: January 27, 2025
Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In.
Journal: Bioconjugate chemistry
Published: August 26, 2024
64Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: January 28, 2024
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 15, 2023
Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.
Journal: ChemMedChem
Published: June 28, 2023
Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5.
Journal: International journal of molecular sciences
Published: April 26, 2023
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.
Journal: Frontiers in immunology
Published: April 12, 2023
Last Updated: 09/26/2026